Stock YMAB Y-MABS THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Y-mAbs Therapeutics, Inc.

Equities

YMAB

US9842411095

Real-time Estimate Cboe BZX
Other stock markets
 10:02:42 2024-05-14 am EDT 		5-day change 1st Jan Change
11.95 USD -1.97% Intraday chart for Y-mAbs Therapeutics, Inc. -29.81% +77.13%
May. 08 Transcript : Y-mAbs Therapeutics, Inc., Q1 2024 Earnings Call, May 08, 2024
May. 07 Earnings Flash (YMAB) Y-MABS THERAPEUTICS Posts Q1 Revenue $19.9M, vs. Street Est of $22.2M MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
Y-MABS THERAPEUTICS, INC. Stock Y-mAbs Therapeutics, Inc.
 535M - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 111B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 105B
BIONTECH SE Stock BioNTech SE
 22.34B -
ARGENX SE Stock argenx SE
 21.93B -
GENMAB A/S Stock Genmab A/S
 18.59B
  1. Stock Market
  2. Equities
  3. YMAB Stock
  4. Charts Y-mAbs Therapeutics, Inc.
  5. Sector Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW